Bivatuzumab
Modify Date: 2024-09-17 10:51:41
Bivatuzumab structure
|
Common Name | Bivatuzumab | ||
|---|---|---|---|---|
| CAS Number | 214559-60-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BivatuzumabBivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells[1]. |
| Name | Bivatuzumab |
|---|
| Description | Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Bivatuzumab (10 μg/mL) 能够标记 STS 细胞中的 CD44v6 [1]。 |
| References |
| No Any Chemical & Physical Properties |